Skip to main content

Advertisement

Log in

Altered Vascular Function, Arterial Stiffness, and Antioxidant Gene Responses in Pediatric Thalassemia Patients

  • Original Article
  • Published:
Pediatric Cardiology Aims and scope Submit manuscript

Abstract

Patients with thalassemia major are susceptible to cardiovascular complications by mechanisms not fully understood. Although overt cardiovascular complications usually occur after puberty, their underlying pathogenesis may begin much earlier. This study investigated whether there were early changes in vascular endothelial function and arterial stiffness in young patients with beta-thalassemia and hemoglobin E, and whether these changes were associated with oxidative stress and expression of antioxidant genes. The study recruited 30 pediatric patients and 30 age-matched control subjects. Compared with the control subjects, the patients had increased levels of oxidant biomarkers including malondialdehyde, protein carbonyl, and non–transferrin-bound iron and a decreased glutathione redox ratio. There were clear signs of vascular endothelial dysfunction and increased arterial stiffness, as shown by marked suppression of forearm blood flow after reactive hyperemia and increased pulse-wave velocity in the trunk and legs. The changes in FBF were associated with oxidative stress markers and free iron. An adaptive antioxidant gene response was activated in blood mononuclear cells, as shown by upregulation of GCLC and Bach-1 mRNA but downregulation of heme oxygenase-1 and thioredoxin mRNA. The results highlight the vascular changes seen even in young patients during treatment. These changes were associated with oxidative stress and suggest an adaptive response that serves to protect host cells from further oxidative damage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Aessopos A, Farmakis D, Hatziliami A, Fragodimitri C, Karabatsos F, Joussef J et al (2004) Cardiac status in well-treated patients with thalassemia major. Eur J Haematol 73:359–366

    Article  PubMed  Google Scholar 

  2. Aessopos A, Farmakis D, Tsironi M, Diamanti-Kandarakis E, Matzourani M, Fragodimiri C et al (2007) Endothelial function and arterial stiffness in sickle-thalassemia patients. Atherosclerosis 191:427–432

    Article  PubMed  CAS  Google Scholar 

  3. Aggeli C, Antoniades C, Cosma C, Chrysohoou C, Tousoulis D, Ladis V et al (2005) Endothelial dysfunction and inflammatory process in transfusion-dependent patients with beta-thalassemia major. Int J Cardiol 105:80–84

    Article  PubMed  Google Scholar 

  4. Aronson D (2003) Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. J Hypertens 21:3–12

    Article  PubMed  CAS  Google Scholar 

  5. Atkinson J (2008) Age-related medial elastocalcinosis in arteries: mechanisms, animal models, and physiological consequences. J Appl Physiol 105:1643–1651

    Article  PubMed  CAS  Google Scholar 

  6. Butthep P, Bunyaratvej A, Funahara Y, Kitaguchi H, Fucharoen S, Sato S et al (1995) Alterations in vascular endothelial cell-related plasma proteins in thalassaemic patients and their correlation with clinical symptoms. Thromb Haemost 74:1045–1049

    PubMed  CAS  Google Scholar 

  7. Chakraborty D, Bhattacharyya M (2001) Antioxidant defense status of red blood cells of patients with beta-thalassemia and Ebeta-thalassemia. Clin Chim Acta 305:123–129

    Article  PubMed  CAS  Google Scholar 

  8. Cheung YF, Chan GC, Ha SY (2002) Arterial stiffness and endothelial function in patients with beta-thalassemia major. Circulation 106:2561–2566

    Article  PubMed  CAS  Google Scholar 

  9. Cunningham MJ, Macklin EA, Neufeld EJ, Cohen AR (2004) Complications of beta-thalassemia major in North America. Blood 104:34–39

    Article  PubMed  CAS  Google Scholar 

  10. Dhakshinamoorthy S, Jain AK, Bloom DA, Jaiswal AK (2005) Bach1 competes with Nrf2 leading to negative regulation of the antioxidant response element (ARE)-mediated NAD(P)H:quinone oxidoreductase 1 gene expression and induction in response to antioxidants. J Biol Chem 280:16891–16900

    Article  PubMed  CAS  Google Scholar 

  11. Domenica Cappellini M, Tavazzi D, Duca L, Marelli S, Fiorelli G (2000) Non–transferrin-bound iron, iron-related oxidative stress, and lipid peroxidation in beta-thalassemia intermedia. Transfus Sci 23:245–246

    Article  PubMed  CAS  Google Scholar 

  12. Farombi EO, Surh YJ (2006) Heme oxygenase-1 as a potential therapeutic target for hepatoprotection. J Biochem Mol Biol 39:479–491

    Article  PubMed  CAS  Google Scholar 

  13. Hahalis G, Alexopoulos D, Kremastinos DT, Zoumbos NC (2005) Heart failure in beta-thalassemia syndromes: a decade of progress. Am J Med 118:957–967

    Article  PubMed  Google Scholar 

  14. Jeyapaul J, Jaiswal AK (2000) Nrf2 and c-Jun regulation of antioxidant response element (ARE)-mediated expression and induction of gamma-glutamylcysteine synthetase heavy subunit gene. Biochem Pharmacol 59:1433–1439

    Article  PubMed  CAS  Google Scholar 

  15. Jison ML, Munson PJ, Barb JJ, Suffredini AF, Talwar S, Logun C et al (2004) Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease. Blood 104:270–280

    Article  PubMed  CAS  Google Scholar 

  16. Jittangprasert P, Wilairat P, Pootrakul P (2004) Comparison of colorimetry and electrothermal atomic absorption spectroscopy for the quantification of non–transferrin-bound iron in human sera. Southeast Asian J Trop Med Public Health 35:1039–1044

    PubMed  CAS  Google Scholar 

  17. Jones DP, Go YM, Anderson CL, Ziegler TR, Kinkade JM Jr, Kirlin WG (2004) Cysteine/cystine couple is a newly recognized node in the circuitry for biologic redox signaling and control. FASEB J 18:1246–1248

    PubMed  CAS  Google Scholar 

  18. Kukongviriyapan V, Somparn N, Senggunprai L, Prawan A, Kukongviriyapan U, Jetsrisuparb A (2008) Endothelial dysfunction and oxidant status in pediatric patients with hemoglobin E-beta thalassemia. Pediatr Cardiol 29:130–135

    Article  PubMed  Google Scholar 

  19. Laurent S, Katsahian S, Fassot C, Tropeano AI, Gautier I, Laloux B et al (2003) Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke 34:1203–1206

    Article  PubMed  Google Scholar 

  20. Loukogeorgakis S, Dawson R, Phillips N, Martyn CN, Greenwald SE (2002) Validation of a device to measure arterial pulse wave velocity by a photoplethysmographic method. Physiol Meas 23:581–596

    Article  PubMed  Google Scholar 

  21. Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, Schalekamp MA et al (2006) Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam study. Circulation 113:657–663

    Article  PubMed  Google Scholar 

  22. Naka KK, Tweddel AC, Doshi SN, Goodfellow J, Henderson AH (2006) Flow-mediated changes in pulse-wave velocity: a new clinical measure of endothelial function. Eur Heart J 27:302–309

    Article  PubMed  Google Scholar 

  23. Nguyen T, Yang CS, Pickett CB (2004) The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress. Free Radic Biol Med 37:433–441

    Article  PubMed  CAS  Google Scholar 

  24. Olivieri NF (1999) The beta-thalassemias. N Engl J Med 341:99–109

    Article  PubMed  CAS  Google Scholar 

  25. Ryter SW, Alam J, Choi AM (2006) Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 86:583–650

    Article  PubMed  CAS  Google Scholar 

  26. Somparn N, Kukongviriyapan U, Tassaneeyakul W, Jetsrisuparb A, Kukongviriyapan V (2007) Modification of CYP2E1 and CYP3A4 activities in haemoglobin E-beta thalassemia patients. Eur J Clin Pharmacol 63:43–50

    Article  PubMed  CAS  Google Scholar 

  27. Surh YJ, Kundu JK, Li MH, Na HK, Cha YN (2009) Role of Nrf2-mediated heme oxygenase-1 upregulation in adaptive survival response to nitrosative stress. Arch Pharm Res 32:1163–1176

    Article  PubMed  CAS  Google Scholar 

  28. Weatherall DJ (2000) Introduction to the problem of hemoglobin E-beta thalassemia. J Pediatr Hematol Oncol 22:551

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

This work was supported by grant-in-aid from Khon Kaen University and a research fund from Faculty of Medicine, Khon Kaen University. The PWV equipment was provided by a British Council PMI2 Grant (#RC53) to Upa Kukongviriyapan and Stephen E. Greenwald.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Veerapol Kukongviriyapan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Detchaporn, P., Kukongviriyapan, U., Prawan, A. et al. Altered Vascular Function, Arterial Stiffness, and Antioxidant Gene Responses in Pediatric Thalassemia Patients. Pediatr Cardiol 33, 1054–1060 (2012). https://doi.org/10.1007/s00246-012-0225-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00246-012-0225-8

Keywords

Navigation